- Book Chapter
1
- 10.1007/978-981-13-7387-9_3
Change of HDL in Various Diseases
- Jan 01, 2019
- Kyung-Hyun Cho
It has been firmly established that coronary heart disease (CHD) is responsible for the vast majority of cases of unstable angina pectoris (AP), acute myocardial infarction (MI), and sudden death. MI is an acute and catastrophic event that results from acute coronary syndrome (ACS) and atherosclerosis, which chronically progresses to ACS (Thygesen et al. 2007). MI is a leading cause of morbidity and mortality in adults in western countries and Asia (Rosamond et al. 2007), and diagnostic biomarkers for MI have been developed and utilized clinically such as serum levels of GOT, LDH, creatine kinase (CK)-MB, and troponin I and T (Jaffe et al. 2000). However, the biomarkers have been limited to clinical use because they had insufficient specificity for predictive MI diagnosis. Furthermore, although many biomarkers have been reported to predict cardiovascular risk, there have been no specific and useful biomarkers developed for the early detection of MI (Pahor et al. 1999). Inflammation is a major risk factor of atherosclerosis, and several inflammatory biomarkers such as hsCRP, cytokines, biomarkers of endothelial cell activation, and proinflammatory enzymes have been established for the diagnosis of ACS (Hartford et al. 2007); however, no studies have been reported to determine if these biomarkers are useful for the prediction of acute MI.
Read more